System and method for augmenting a humoral immune response

• US 20080059136A1
• Filed: 08/28/2007
• Published: 03/06/2008
• Est. Priority Date: 12/03/2004
• Status: Abandoned Application

• Current Assignee: Searete LLC (Intellectual Ventures LLC)
• Original Assignee: Searete LLC (Intellectual Ventures LLC)
• Inventors: Jung, Edward, Wilson, Richa, Myhrvold, Nathan, Wood, Lowell, Ishikawa, Muriel
• Application Number:
  US11/897,103
• Publication Number:
  US 20080059136A1
• Time in Patent Office: Days
• US Class Current: 703/11
• CPC Class Codes: A61K 31/55 having seven-membered rings, e.g. azelastine, pentylenetetrazole
• CPC Class Codes: A61K 39/00 Medicinal preparations containing antigens or antibodies materials for immunoassay G01N33/53
• CPC Class Codes: A61K 39/02 Bacterial antigens
• CPC Class Codes: Y02A 50/30 Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

The present application relates, in general, to a system and/or method for detection and/or treatment.

Claims

1-53. -53. (canceled)

54. A system, comprising:

circuitry for associating at least one computable antigen of one or more agents with at least a part of an immune response;

circuitry for projecting a pattern of one or more changes relating to the at least one computable antigen of the one or more agents; and

circuitry for selecting one or more immune response components responsive to said circuitry for projecting.

61. The system of claim 54, wherein the circuitry for associating at least one computable antigen of one or more agents with at least a part of an immune response comprises:

circuitry for identifying an association of at least one computable antigen with one or more agents wherein at least one of the one or more agents is a putative causative agent of a disease.

62. The system of claim 54, wherein the circuitry for associating of at least one computable antigen of one or more agents with at least a part of an immune response comprises:

circuitry for identifying an association of at least one computable antigen with one or more agents wherein at least one of the one or more agents is an agent belonging to the same family or group as the agent of primary interest.

63. The system of claim 54, wherein the circuitry for associating of at least one computable antigen of one or more agents with at least a part of an immune response comprises:

circuitry for identifying an association of at least one computable antigen with one or more agents wherein at least one of the one or more agents is an agent exhibiting a common function relative to the agent of primary interest.

66. The system of claim 54, wherein the circuitry for selecting one or more immune response components responsive to said circuitry for projecting comprises:

circuitry for selecting at least a part of at least one B-lymphocyte.

67. The system of claim 54, wherein the circuitry for selecting one or more immune response components responsive to said circuitry for projecting comprises:

circuitry for selecting one or more modulators of at least a part of a B-lymphocyte.

70. The system of claim 54, wherein the circuitry for selecting one or more immune response components responsive to said circuitry for projecting comprises:

circuitry for selecting one or more immune response components specific to the conformational state of a protein.

71. The system of claim 54, wherein the circuitry for selecting one or more immune response components responsive to said circuitry for projecting comprises:

circuitry for selecting one or more immune response components including one or more effector molecules.

72. The system of claim 54, wherein the circuitry for selecting one or more immune response components responsive to said circuitry for projecting comprises:

circuitry for selecting one or more immune response components with physico-chemical properties optimized by computer-based screening methods.

73. The system of claim 54, wherein the circuitry for selecting one or more immune response components responsive to said circuitry for projecting comprises:

circuitry for selecting one or more immune response components designed to include accommodations in its design arising from the prediction of mutational changes in an epitope.

74. The system of claim 54, wherein the circuitry for selecting one or more immune response components responsive to said circuitry for projecting comprises:

circuitry for selecting one or more immune response components designed for binding to the smallest effective determinant.

55. (canceled)

56. A system, comprising:

circuitry for accepting an input of one or more agents; and

circuitry for identifying an association of at least one computable antigen of one or more agents with at least a part of an immune response related to suppressing the one or more agents.

75. The system of claim 56, wherein the circuitry for accepting an input of one or more agents comprises:

circuitry for accepting input via a medical system.

76. The system of claim 56, wherein the circuitry for accepting an input of one or more agents comprises:

circuitry for accepting input including criteria related to the agent.

78. The system of claim 56, wherein the circuitry for identifying an association of at least one computable antigen of one or more agents with at least a part of an immune response comprises:

circuitry for identifying an association of at least one computable antigen with one or more agents wherein at least one of the one or more agents is a putative causative agent of a disease.

79. The system of claim 56, wherein the circuitry for identifying an association of at least one computable antigen of one or more agents with at least a part of an immune response comprises:

circuitry for identifying an association of at least one computable antigen with one or more agents wherein at least one of the one or more agents is an agent belonging to the same family or group as the agent of primary interest.

80. The system of claim 56, wherein the circuitry for identifying an association of at least one computable antigen of one or more agents with at least a part of an immune response comprises:

circuitry for identifying an association of at least one computable antigen with one or more agents wherein at least one of the one or more agents is an agent exhibiting a common function relative to the agent of primary interest.

57. (canceled)

58. A system, comprising:

circuitry for projecting a pattern of one or more changes relating to at least one computable antigen of one or more agents; and

circuitry for selecting one or more immune response components in response to said projecting.

83. The system of claim 58, wherein the circuitry for selecting one or more immune response components in response to the projecting comprises:

circuitry for selecting at least a part of at least one B-lymphocyte.

84. The system of claim 58, wherein the circuitry for selecting one or more immune response components in response to the projecting comprises:

circuitry for selecting one or more modulators of at least a part of a B-lymphocyte.

87. The system of claim 58, wherein the circuitry for selecting one or more immune response components in response to the projecting comprises:

circuitry for selecting one or more immune response components specific to the conformational state of a protein.

88. The system of claim 58, wherein the circuitry for selecting one or more immune response components in response to the projecting comprises:

circuitry for selecting one or more immune response components including one or more effector molecules.

89. The system of claim 58, wherein the circuitry for selecting one or more immune response components in response to the projecting comprises:

circuitry for selecting one or more immune response components with physico-chemical properties optimized by computer-based screening methods.

90. The system of claim 58, wherein the circuitry for selecting one or more immune response components in response to the projecting comprises:

circuitry for selecting one or more immune response components designed to include accommodations in its design arising from the prediction of mutational changes in an epitope.

91. The system of claim 58, wherein the circuitry for selecting one or more immune response components in response to the projecting comprises:

circuitry for selecting one or more immune response components designed for binding to the smallest effective determinant.

59. (canceled)

60. (canceled)

64. (canceled)

65. (canceled)

68. (canceled)

69. (canceled)

77. (canceled)

81. (canceled)

82. (canceled)

85. (canceled)

86. (canceled)